Edgewise Therapeutics
Matt Dreitz is an experienced clinical operations professional currently serving as the Associate Director of Clinical Operations at Edgewise Therapeutics since December 2023. Prior to this role, Matt held the position of Senior Study Manager within the Parexel FSP on assignment with Pfizer from October 2022 to December 2023. Matt's career includes significant roles such as Associate Director of Clinical Operations at ARCA biopharma, Inc., and Principal Clinical Team Manager at PPD. With a history of advancing projects within various organizations, Matt has also held key positions at Ablative Solutions, ARCA biopharma, Inviragen, Inc./Takeda Vaccines, and Gilead Sciences, demonstrating a strong background in clinical management and team leadership across multiple facets of the healthcare industry.
This person is not in any teams
This person is not in any offices